seed
Stage
1
Investors
About
Evolvere BioSciences develops next-generation antibiotics using computational models and AI to forecast bacterial mutations and design therapies that precisely target pathogenic bacteria while sparing beneficial microbes and human cells.
Explore Evolvere BioSciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.